Association of Depression With 10-Year and Lifetime Cardiovascular Disease Risk Among US Adults, National Health and Nutrition Examination Survey, 2005-2018.


Journal

Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018

Informations de publication

Date de publication:
26 05 2022
Historique:
entrez: 26 5 2022
pubmed: 27 5 2022
medline: 31 5 2022
Statut: epublish

Résumé

Although an association between depression and incident cardiovascular disease (CVD) risk has been established, no US studies have quantified this association using standard primary care assessments or among younger adults who are not routinely screened for CVD risk. We estimated the association of mild and major depression with 1) 10-year atherosclerotic CVD (ASCVD) risk for people aged 40 to 79 years and 2) high lifetime CVD risk prevalence for people aged 20 to 39 years. We conducted a cross-sectional analysis of data from the 2005-2018 National Health and Nutrition Examination Survey for adults aged 20 to 39 years (n = 10,588) and adults aged 40 to 79 years (n = 16,848). We used the Patient Health Questionnaire-9 [PHQ-9] to classify no depression (PHQ-9 score, 0-4), mild depression (PHQ-9 score, 5-9) and major depression (PHQ-9 score ≥10). Among women aged 40 to 79, ASCVD absolute risk was 6.0% for no depression, 6.9% for mild depression, and 7.6% for major depression (P < .001 vs no depression). Among men aged 40 to 79, the corresponding absolute ASCVD risks were 9.9%, 11.1%, and 11.3%, respectively (P < .001 vs no depression). High lifetime CVD risk prevalence for women aged 20 to 39 was 41.9% for no depression, 53.2% for mild depression, and 66.5% for major depression (P < .001 vs no depression). For men aged 20-39 the corresponding high lifetime risk percentages were 53.3%, 64.8%, and 74.4% respectively (P < .001 vs no depression). Mild and major depression are associated with elevated 10-year ASCVD risk and substantially elevated lifetime CVD risk among younger people ineligible for ASCVD risk assessment. Jointly addressing depression and CVD risk and extending prevention efforts to younger adults are warranted.

Identifiants

pubmed: 35617679
doi: 10.5888/pcd19.210418
pii: E28
pmc: PMC9165473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E28

Références

BMC Public Health. 2014 Mar 24;14:273
pubmed: 24656048
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
Ann Intern Med. 2020 Jun 16;172(12):803-809
pubmed: 32422056
Psychosom Med. 2014 Jan;76(1):29-37
pubmed: 24367124
BMC Psychiatry. 2019 Apr 26;19(1):125
pubmed: 31027490
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
JAMA Cardiol. 2020 Dec 1;5(12):1425-1429
pubmed: 32876652
J Affect Disord. 2019 Jun 1;252:450-457
pubmed: 31004825
BMC Psychiatry. 2014 Dec 24;14:371
pubmed: 25540022
NCHS Data Brief. 2018 Feb;(303):1-8
pubmed: 29638213
Int J Epidemiol. 1985 Mar;14(1):32-8
pubmed: 3872850
Psychosom Med. 2016 Jun;78(5):602-9
pubmed: 26867076
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Comp Eff Res. 2014 Sep;3(5):473-80
pubmed: 25350799
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
Lancet. 2018 Nov 24;392(10161):2299-2312
pubmed: 30396512
Arch Gen Psychiatry. 2002 Jun;59(6):530-7
pubmed: 12044195
JAMA. 2020 Dec 15;324(23):2396-2405
pubmed: 33320224
BMJ. 2019 Apr 8;365:l794
pubmed: 30962184
NCHS Data Brief. 2020 Sep;(379):1-8
pubmed: 33054920
Circulation. 2021 Feb 23;143(8):837-851
pubmed: 33617315
Circulation. 2006 Feb 14;113(6):791-8
pubmed: 16461820
N Engl J Med. 2012 Jan 26;366(4):321-9
pubmed: 22276822
JAMA Psychiatry. 2021 Apr 1;78(4):416-425
pubmed: 33439216
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
Diabetes Care. 2000 Jan;23 Suppl 1:S4-19
pubmed: 12017675
Circulation. 2021 Mar 9;143(10):e763-e783
pubmed: 33486973
PLoS One. 2016 Apr 22;11(4):e0153838
pubmed: 27105076
Circulation. 2015 Sep 8;132(10):965-86
pubmed: 26260736
Vital Health Stat 2. 2020 Apr;(184):1-35
pubmed: 33663649
Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):8-14
pubmed: 20123666
J Gen Intern Med. 2021 Aug 17;:
pubmed: 34405346
JAMA Psychiatry. 2020 Nov 1;77(11):1095-1096
pubmed: 32579156
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
J Affect Disord. 2016 Aug;200:235-42
pubmed: 27148902
World J Biol Psychiatry. 2010 Sep;11(6):834-9
pubmed: 20632843

Auteurs

Steven D Barger (SD)

Department of Psychological Sciences, Northern Arizona University, 1100 South Beaver St, Building 60, Room 338, Flagstaff, AZ 86011. Email: steven.barger@nau.edu.

Gabrielle C Struve (GC)

Department of Psychological Sciences, Northern Arizona University, Flagstaff, Arizona.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH